REPLINVI Trademark
Serial Number: 79326847 • Registration: 6726959
REPLINVI is a trademark filed by
NOVARTIS AG
on October 8, 2021. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Maury M. Tepper, III Tepper & Eyster, PLLC
3724 BENSON DR
RALEIGH
NC 27609
United States
Trademark Details
Filing Date
October 8, 2021
Registration Date
May 24, 2022
Published for Opposition
March 1, 2022
Filing History
NOTIFICATION PROCESSED BY IB
Sep 11, 2022 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Aug 18, 2022 FICS
FINAL DISPOSITION PROCESSED
Aug 17, 2022 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jun 23, 2022 GPAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 24, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
May 24, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 1, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Feb 27, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 9, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 9, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 9, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 27, 2022 PREV
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 26, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 26, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 26, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 26, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 26, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 26, 2022 COAR
ASSIGNED TO LIE
Jan 24, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 21, 2022 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 21, 2022 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 21, 2022 CNSA
ASSIGNED TO EXAMINER
Jan 21, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 17, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 9, 2021 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Nov 25, 2021 SDRC
